Clinical Trial

The Role of Laryngopharyngeal Reflux in IPF

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2018-01-30; most recent amendment 2024-11-12.
Status change: Not Yet Recruiting → Recruiting 2018-08-23
Trial Details
NCT Number NCT03418350
Lead Sponsor National Jewish Health
Conditions IPF, Reflux
Enrollment 60 participants
Start Date 2018-08-01
Primary Completion 2025-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-11-14